Toronto Dominion Bank
KRYS icon

Toronto Dominion Bank’s Krystal Biotech KRYS Stock Holding History

Toronto Dominion Bank’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.7K Buy
+96
New +$28.7K ﹤0.01% 1948
2022
Q1 		– Sell
-8,108
Closed -$567K – 1716
2021
Q4 		$567K Buy
+8,108
New +$472K ﹤0.01% 1163

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Toronto Dominion Bank's KRYS Position: Q2 2026 in Review

Toronto Dominion Bank opened a new position in Krystal Biotech (KRYS) in Q2 2026: 96 shares worth $35.7K. The stake represents ﹤0.01% of the portfolio and ranks #1948 among its holdings. This is a return to the name: Toronto Dominion Bank previously reported a position in KRYS as recently as Q4 2021.

Toronto Dominion Bank first reported a position in KRYS in Q4 2021 and has held it in 2 quarters since. The position peaked at $567K in Q4 2021. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Toronto Dominion Bank held 96 shares of Krystal Biotech worth $35.7K as of Q2 2026.
  • Krystal Biotech was a new Toronto Dominion Bank position in Q2 2026.
  • Krystal Biotech made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1948 holding.
  • Toronto Dominion Bank first reported a position in Krystal Biotech in Q4 2021 and has held it in 2 quarters since.
  • Toronto Dominion Bank's Krystal Biotech position peaked at $567K in Q4 2021.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.